FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Board games and firepits: Senior communities are pulling out all the stops to lure Generation X. Here’s why.
Retirement communities are courting members of Gen X, who will outnumber baby boomers in 2028.
Young traders don’t care if stocks and crypto are in a bubble. They could get a rude awakening.
A new survey found that the majority of active traders are bullish, despite some thinking the market is in a bubble.
This energy-drink stock is rallying thanks to a $1.8 billion acquisition
Celsius shares are up more than 30% after its quarterly results topped estimates and it announced plans to buy Alani Nu.
Should Broadcom really buy parts of Intel? It could be ‘extremely lucrative.’
Broadcom would only be interested in Intel’s core PC- and server-chip units, Piper Sandler speculated.
Consumer sentiment sours as worries grow over outlook for U.S. economy
Confidence dropped 10% from January to the lowest level since late 2023.